|

Carboplatin (AUC 5) Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 2

Top Sponsors

  • Xijing Hospital1
  • CatalYm GmbH1
  • Akeso1

Indications

  • Cancer3
  • Lung Cancer2
  • Adult Solid Tumor1
  • Metastatic Non-squamous Non Small Cell Lung Cancer1
  • TNBC - Triple-Negative Breast Cancer1

Other2 trials

A Study of Ivonescimab in First-Line ES-SCLC
Phase 2
A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
Phase 1

Birmingham, Alabama1 trial

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.